Obsidio, Inc. is an early-stage medical device company focused on developing a minimally-invasive occlusive agent using a shear-thinning biomaterial (STB) technology for applications in vascular embolotherapy.
Location: United States, South Carolina
Employees: 1-10
Total raised: $3M
Founded date: 2018
Investors 2
| Date | Name | Website |
| - | Charleston... | chapsc.com |
| - | Good Growt... | goodgrowth... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.08.2020 | Grant | $3M | - |
Mentions in press and media 2
| Date | Title | Description |
| 07.08.2020 | Obsidio Closes $3M Round, Receives Grant from The National Science Foundation | Obsidio, Inc., a Columbia, S.C.-based pre-clinical stage medical materials developer, closed a $3m funding round. The round was led by IAG Capital Partners with participation from returning investors Good Growth Capital and other angel inve... |
| 25.07.2019 | TMCx announces its next medical device cohort with 5 startups hailing from Houston | The Texas Medical Center's startup accelerator, TMCx, has added 19 companies from all around the world to join its medical device family. The TMC Innovation Institute team narrowed down 140 applications to 40 for the second round of the pro... |